Published in Rapid Commun Mass Spectrom on January 01, 2006
Techniques for accurate protein identification in shotgun proteomic studies of human, mouse, bovine, and chicken lenses. J Ocul Biol Dis Infor (2009) 1.25
Protein-Sequence Polymorphisms and Post-translational Modifications in Proteins from Human Saliva using Top-Down Fourier-transform Ion Cyclotron Resonance Mass Spectrometry. Int J Mass Spectrom (2007) 1.22
Detection, evaluation and minimization of nonenzymatic deamidation in proteomic sample preparation. Mol Cell Proteomics (2011) 1.18
Use of 18O labels to monitor deamidation during protein and peptide sample processing. J Am Soc Mass Spectrom (2008) 1.18
Simultaneous assessment of Asp isomerization and Asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. PLoS One (2012) 0.98
Mechanisms of glucagon degradation at alkaline pH. Peptides (2013) 0.93
Lens β-crystallins: the role of deamidation and related modifications in aging and cataract. Prog Biophys Mol Biol (2014) 0.91
Deamidation of alpha-synuclein. Protein Sci (2009) 0.80
Characterization of deamidation of barstar using electrospray ionization quadrupole time-of-flight mass spectrometry, which stabilizes an equilibrium unfolding intermediate. Protein Sci (2012) 0.80
Determination of dideoxyosone precursors of AGEs in human lens proteins. Arch Biochem Biophys (2011) 0.75
The Separation and Quantitation of Peptides with and without Oxidation of Methionine and Deamidation of Asparagine Using Hydrophilic Interaction Liquid Chromatography with Mass Spectrometry (HILIC-MS). J Am Soc Mass Spectrom (2017) 0.75
Dual-pressure linear ion trap mass spectrometer improving the analysis of complex protein mixtures. Anal Chem (2009) 2.20
Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal Chem (2006) 2.03
A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. J Proteome Res (2008) 1.92
Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol Cell Proteomics (2010) 1.71
Top-down ESI-ECD-FT-ICR mass spectrometry localizes noncovalent protein-ligand binding sites. J Am Chem Soc (2006) 1.68
A nonsense mutation in CRYBB1 associated with autosomal dominant cataract linked to human chromosome 22q. Am J Hum Genet (2002) 1.57
Multiplexed MS/MS for improved data-independent acquisition. Nat Methods (2013) 1.48
Kif7 regulates Gli2 through Sufu-dependent and -independent functions during skin development and tumorigenesis. Development (2012) 1.28
Top-down mass spectrometry of integral membrane proteins. Expert Rev Proteomics (2006) 1.27
Deamidation, but not truncation, decreases the urea stability of a lens structural protein, betaB1-crystallin. Biochemistry (2002) 1.25
Protein-Sequence Polymorphisms and Post-translational Modifications in Proteins from Human Saliva using Top-Down Fourier-transform Ion Cyclotron Resonance Mass Spectrometry. Int J Mass Spectrom (2007) 1.22
Deamidation destabilizes and triggers aggregation of a lens protein, betaA3-crystallin. Protein Sci (2008) 1.20
Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene (2004) 1.19
Deamidation alters the structure and decreases the stability of human lens betaA3-crystallin. Biochemistry (2007) 1.18
Novel parallelized quadrupole/linear ion trap/Orbitrap tribrid mass spectrometer improving proteome coverage and peptide identification rates. Anal Chem (2013) 1.15
The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol Dis (2007) 1.09
Deamidation alters interactions of beta-crystallins in hetero-oligomers. Mol Vis (2009) 1.08
Quantitative measurement of young human eye lens crystallins by direct injection Fourier transform ion cyclotron resonance mass spectrometry. Mol Vis (2006) 1.07
Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer. J Am Soc Mass Spectrom (2009) 1.03
Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): Implications for downstream process development. Biotechnol Bioeng (2010) 1.02
Laser light-scattering evidence for an altered association of beta B1-crystallin deamidated in the connecting peptide. Protein Sci (2004) 1.02
Quantification of post-translationally modified peptides of bovine alpha-crystallin using tandem mass tags and electron transfer dissociation. J Proteomics (2009) 1.01
Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase. Antimicrob Agents Chemother (2012) 0.97
Oncogenic Ras-mediated downregulation of Gadd153/CHOP is required for Ras-induced cellular transformation. Oncogene (2005) 0.95
Amide molecular clocks in drosophila proteins: potential regulators of aging and other processes. Mech Ageing Dev (2004) 0.92
New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp Eye Res (2010) 0.91
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia. Proteomics (2009) 0.90
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest (2010) 0.89
Evaluation of front-end higher energy collision-induced dissociation on a benchtop dual-pressure linear ion trap mass spectrometer for shotgun proteomics. Anal Chem (2012) 0.89
Quantitative measurement of deamidation in lens betaB2-crystallin and peptides by direct electrospray injection and fragmentation in a Fourier transform mass spectrometer. Mol Vis (2005) 0.89
Aggregation of deamidated human betaB2-crystallin and incomplete rescue by alpha-crystallin chaperone. Exp Eye Res (2010) 0.87
Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation. Invest Ophthalmol Vis Sci (2010) 0.86
Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody Fab fragment. J Pharm Sci (2012) 0.84
FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene (2005) 0.84
Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. Anal Chem (2012) 0.84
Micro-heterogeneity of human saliva Peptide P-C characterized by high-resolution top-down Fourier-transform mass spectrometry. J Am Soc Mass Spectrom (2010) 0.82
Use of Merrifield solid phase peptide synthesis in investigations of biological deamidation of peptides and proteins. Biopolymers (2008) 0.81
Associations of seroreactivity against crystallin proteins with disease activity and cataract in patients with uveitis. Invest Ophthalmol Vis Sci (2008) 0.81
Solvent accessibility of betaB2-crystallin and local structural changes due to deamidation at the dimer interface. Exp Eye Res (2010) 0.80
Investigation of collision-induced dissociations involving odd-electron ion formation under positive electrospray ionization conditions using accurate mass. Rapid Commun Mass Spectrom (2010) 0.77
Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment. J Pharm Sci (2013) 0.76
Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection. J Med Chem (2013) 0.76
Structural and Functional Characterization of a Hole-Hole Homodimer Variant in a "Knob-Into-Hole" Bispecific Antibody. Anal Chem (2017) 0.75
N-Acetylcysteine Prevents Retrograde Motor Neuron Death after Neonatal Peripheral Nerve Injury. Plast Reconstr Surg (2017) 0.75
Leachables from saline-containing IV bags can alter therapeutic protein properties. Pharm Res (2010) 0.75
Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors. Bioorg Med Chem Lett (2003) 0.75
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH. Bioorg Med Chem Lett (2006) 0.75
Maximizing binding capacity for protein A chromatography. Biotechnol Prog (2014) 0.75